nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—CYP2C8—Metabolism—GCH1—Parkinson's disease	0.000389	0.000389	CbGpPWpGaD
Naproxen—ALB—Metabolism—GCH1—Parkinson's disease	0.000387	0.000387	CbGpPWpGaD
Naproxen—AKR1C3—Disease—APOE—Parkinson's disease	0.000385	0.000385	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000381	0.000381	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—GPX1—Parkinson's disease	0.000376	0.000376	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ND3—Parkinson's disease	0.000372	0.000372	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MCCC1—Parkinson's disease	0.000372	0.000372	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GSTA4—Parkinson's disease	0.000372	0.000372	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CYP2D6—Parkinson's disease	0.000372	0.000372	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000367	0.000367	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CTGF—Parkinson's disease	0.000365	0.000365	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000351	0.000351	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000351	0.000351	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—OMD—Parkinson's disease	0.00035	0.00035	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—TALDO1—Parkinson's disease	0.00035	0.00035	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000349	0.000349	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IGF2—Parkinson's disease	0.000347	0.000347	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—MTHFR—Parkinson's disease	0.000347	0.000347	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GBA—Parkinson's disease	0.000347	0.000347	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—DBH—Parkinson's disease	0.000347	0.000347	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—FBP1—Parkinson's disease	0.000347	0.000347	CbGpPWpGaD
Naproxen—ALB—Metabolism—GBA—Parkinson's disease	0.000345	0.000345	CbGpPWpGaD
Naproxen—ALB—Metabolism—DBH—Parkinson's disease	0.000345	0.000345	CbGpPWpGaD
Naproxen—ALB—Metabolism—FBP1—Parkinson's disease	0.000345	0.000345	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CYP2E1—Parkinson's disease	0.00034	0.00034	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	0.000338	0.000338	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IL6—Parkinson's disease	0.000337	0.000337	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—NQO1—Parkinson's disease	0.000336	0.000336	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IGF1R—Parkinson's disease	0.000336	0.000336	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PLA2G6—Parkinson's disease	0.000335	0.000335	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—EDN1—Parkinson's disease	0.000332	0.000332	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	0.000332	0.000332	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—MAOB—Parkinson's disease	0.000331	0.000331	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—TH—Parkinson's disease	0.000331	0.000331	CbGpPWpGaD
Naproxen—AKR1C3—Disease—INS—Parkinson's disease	0.000329	0.000329	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL6—Parkinson's disease	0.000329	0.000329	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CYP2D6—Parkinson's disease	0.000324	0.000324	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—APOE—Parkinson's disease	0.000323	0.000323	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—CYCS—Parkinson's disease	0.000318	0.000318	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ND3—Parkinson's disease	0.000318	0.000318	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MCCC1—Parkinson's disease	0.000318	0.000318	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CTGF—Parkinson's disease	0.000318	0.000318	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GCH1—Parkinson's disease	0.000316	0.000316	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000315	0.000315	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—DDC—Parkinson's disease	0.000313	0.000313	CbGpPWpGaD
Naproxen—PTGS2—Disease—RPL23A—Parkinson's disease	0.000308	0.000308	CbGpPWpGaD
Naproxen—PTGS2—Disease—RPL14—Parkinson's disease	0.000308	0.000308	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—NGF—Parkinson's disease	0.000305	0.000305	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CYP2D6—Parkinson's disease	0.000302	0.000302	CbGpPWpGaD
Naproxen—ALB—Hemostasis—SOD1—Parkinson's disease	0.000302	0.000302	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	0.000301	0.000301	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—TALDO1—Parkinson's disease	0.000299	0.000299	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—OMD—Parkinson's disease	0.000299	0.000299	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CTGF—Parkinson's disease	0.000297	0.000297	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CYP2E1—Parkinson's disease	0.000296	0.000296	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GSTA4—Parkinson's disease	0.000295	0.000295	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—NQO1—Parkinson's disease	0.000293	0.000293	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000291	0.000291	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—HTR2A—Parkinson's disease	0.00029	0.00029	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—CYCS—Parkinson's disease	0.000289	0.000289	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—TH—Parkinson's disease	0.000289	0.000289	CbGpPWpGaD
Naproxen—ALB—Hemostasis—ABL1—Parkinson's disease	0.000288	0.000288	CbGpPWpGaD
Naproxen—PTGS2—Disease—FGF20—Parkinson's disease	0.000287	0.000287	CbGpPWpGaD
Naproxen—PTGS2—Disease—RPS8—Parkinson's disease	0.000287	0.000287	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IGF2—Parkinson's disease	0.000286	0.000286	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000285	0.000285	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	0.000283	0.000283	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—FBP1—Parkinson's disease	0.000282	0.000282	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—DBH—Parkinson's disease	0.000282	0.000282	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GBA—Parkinson's disease	0.000282	0.000282	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—COMT—Parkinson's disease	0.000282	0.000282	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GSTP1—Parkinson's disease	0.00028	0.00028	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—MAOA—Parkinson's disease	0.00028	0.00028	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000277	0.000277	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—CYCS—Parkinson's disease	0.000277	0.000277	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—HMOX1—Parkinson's disease	0.000277	0.000277	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CYP2E1—Parkinson's disease	0.000276	0.000276	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—INS—Parkinson's disease	0.000276	0.000276	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—NQO1—Parkinson's disease	0.000273	0.000273	CbGpPWpGaD
Naproxen—ALB—Hemostasis—HGF—Parkinson's disease	0.00027	0.00027	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GCH1—Parkinson's disease	0.00027	0.00027	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—APOE—Parkinson's disease	0.00027	0.00027	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—TH—Parkinson's disease	0.000269	0.000269	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PLA2G6—Parkinson's disease	0.000266	0.000266	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ABCB1—Parkinson's disease	0.000265	0.000265	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—MAOB—Parkinson's disease	0.000263	0.000263	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—CYCS—Parkinson's disease	0.000259	0.000259	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GSTM1—Parkinson's disease	0.000258	0.000258	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—DDC—Parkinson's disease	0.000254	0.000254	CbGpPWpGaD
Naproxen—ALB—Metabolism—DDC—Parkinson's disease	0.000253	0.000253	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.000251	0.000251	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.00025	0.00025	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—GPX1—Parkinson's disease	0.000247	0.000247	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CYP2D6—Parkinson's disease	0.000246	0.000246	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—COMT—Parkinson's disease	0.000245	0.000245	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GSTP1—Parkinson's disease	0.000244	0.000244	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000244	0.000244	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—MAOA—Parkinson's disease	0.000244	0.000244	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CTGF—Parkinson's disease	0.000242	0.000242	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000241	0.000241	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GBA—Parkinson's disease	0.000241	0.000241	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—FBP1—Parkinson's disease	0.000241	0.000241	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—DBH—Parkinson's disease	0.000241	0.000241	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—HMOX1—Parkinson's disease	0.000241	0.000241	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GSTA4—Parkinson's disease	0.00024	0.00024	CbGpPWpGaD
Naproxen—ALB—Metabolism—GSTA4—Parkinson's disease	0.000239	0.000239	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000237	0.000237	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000236	0.000236	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ABCB1—Parkinson's disease	0.000231	0.000231	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—INS—Parkinson's disease	0.000231	0.000231	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—COMT—Parkinson's disease	0.000229	0.000229	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GSTP1—Parkinson's disease	0.000228	0.000228	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—MTHFR—Parkinson's disease	0.000228	0.000228	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—MAOA—Parkinson's disease	0.000227	0.000227	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CYP2E1—Parkinson's disease	0.000225	0.000225	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—HMOX1—Parkinson's disease	0.000225	0.000225	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GSTM1—Parkinson's disease	0.000224	0.000224	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—NQO1—Parkinson's disease	0.000223	0.000223	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—TH—Parkinson's disease	0.00022	0.00022	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	0.000216	0.000216	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ABCB1—Parkinson's disease	0.000216	0.000216	CbGpPWpGaD
Naproxen—ALB—Metabolism—PLA2G6—Parkinson's disease	0.000215	0.000215	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—GPX1—Parkinson's disease	0.000215	0.000215	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—MAOB—Parkinson's disease	0.000214	0.000214	CbGpPWpGaD
Naproxen—ALB—Metabolism—MAOB—Parkinson's disease	0.000213	0.000213	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—APOE—Parkinson's disease	0.000212	0.000212	CbGpPWpGaD
Naproxen—PTGS2—Disease—ADRBK1—Parkinson's disease	0.000211	0.000211	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—CYCS—Parkinson's disease	0.000211	0.000211	CbGpPWpGaD
Naproxen—PTGS2—Disease—HSPA1A—Parkinson's disease	0.00021	0.00021	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GSTM1—Parkinson's disease	0.000209	0.000209	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—DDC—Parkinson's disease	0.000207	0.000207	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000204	0.000204	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000203	0.000203	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—GPX1—Parkinson's disease	0.000201	0.000201	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—MTHFR—Parkinson's disease	0.000198	0.000198	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CYP2D6—Parkinson's disease	0.000196	0.000196	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTA4—Parkinson's disease	0.000195	0.000195	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000193	0.000193	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CTGF—Parkinson's disease	0.000192	0.000192	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—COMT—Parkinson's disease	0.000187	0.000187	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GSTP1—Parkinson's disease	0.000186	0.000186	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—MAOA—Parkinson's disease	0.000185	0.000185	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—MTHFR—Parkinson's disease	0.000185	0.000185	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—APOE—Parkinson's disease	0.000185	0.000185	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—HMOX1—Parkinson's disease	0.000183	0.000183	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—INS—Parkinson's disease	0.000181	0.000181	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CYP2E1—Parkinson's disease	0.000179	0.000179	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—DDC—Parkinson's disease	0.000177	0.000177	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—NQO1—Parkinson's disease	0.000177	0.000177	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	0.000176	0.000176	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ABCB1—Parkinson's disease	0.000176	0.000176	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—TH—Parkinson's disease	0.000174	0.000174	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MAOB—Parkinson's disease	0.000174	0.000174	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—APOE—Parkinson's disease	0.000172	0.000172	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CASP3—Parkinson's disease	0.000172	0.000172	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GSTM1—Parkinson's disease	0.000171	0.000171	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—CYCS—Parkinson's disease	0.000167	0.000167	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTA4—Parkinson's disease	0.000167	0.000167	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000166	0.000166	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000165	0.000165	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—GPX1—Parkinson's disease	0.000164	0.000164	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	0.000159	0.000159	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP2D6—Parkinson's disease	0.000158	0.000158	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—INS—Parkinson's disease	0.000158	0.000158	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MAPK8—Parkinson's disease	0.000158	0.000158	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CTGF—Parkinson's disease	0.000156	0.000156	CbGpPWpGaD
Naproxen—ALB—Metabolism—CTGF—Parkinson's disease	0.000155	0.000155	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—MTHFR—Parkinson's disease	0.000151	0.000151	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	0.00015	0.00015	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MAOB—Parkinson's disease	0.000149	0.000149	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—COMT—Parkinson's disease	0.000148	0.000148	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GSTP1—Parkinson's disease	0.000147	0.000147	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—INS—Parkinson's disease	0.000147	0.000147	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—MAOA—Parkinson's disease	0.000147	0.000147	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	0.000146	0.000146	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—HMOX1—Parkinson's disease	0.000145	0.000145	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYP2E1—Parkinson's disease	0.000145	0.000145	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NQO1—Parkinson's disease	0.000144	0.000144	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IL6—Parkinson's disease	0.000144	0.000144	CbGpPWpGaD
Naproxen—ALB—Metabolism—NQO1—Parkinson's disease	0.000143	0.000143	CbGpPWpGaD
Naproxen—PTGS2—Disease—MTHFR—Parkinson's disease	0.000143	0.000143	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—TH—Parkinson's disease	0.000142	0.000142	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000142	0.000142	CbGpPWpGaD
Naproxen—ALB—Metabolism—TH—Parkinson's disease	0.000141	0.000141	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—APOE—Parkinson's disease	0.00014	0.00014	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ABCB1—Parkinson's disease	0.00014	0.00014	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—CYCS—Parkinson's disease	0.000136	0.000136	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GSTM1—Parkinson's disease	0.000136	0.000136	CbGpPWpGaD
Naproxen—ALB—Metabolism—CYCS—Parkinson's disease	0.000135	0.000135	CbGpPWpGaD
Naproxen—PTGS2—Disease—APOE—Parkinson's disease	0.000133	0.000133	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—GPX1—Parkinson's disease	0.00013	0.00013	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	0.000129	0.000129	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CTGF—Parkinson's disease	0.000127	0.000127	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—COMT—Parkinson's disease	0.000121	0.000121	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GSTP1—Parkinson's disease	0.00012	0.00012	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—INS—Parkinson's disease	0.00012	0.00012	CbGpPWpGaD
Naproxen—ALB—Metabolism—COMT—Parkinson's disease	0.00012	0.00012	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—MTHFR—Parkinson's disease	0.00012	0.00012	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—MAOA—Parkinson's disease	0.00012	0.00012	CbGpPWpGaD
Naproxen—ALB—Metabolism—GSTP1—Parkinson's disease	0.000119	0.000119	CbGpPWpGaD
Naproxen—ALB—Metabolism—MAOA—Parkinson's disease	0.000119	0.000119	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	0.000118	0.000118	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—HMOX1—Parkinson's disease	0.000118	0.000118	CbGpPWpGaD
Naproxen—ALB—Metabolism—HMOX1—Parkinson's disease	0.000118	0.000118	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NQO1—Parkinson's disease	0.000117	0.000117	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—TH—Parkinson's disease	0.000115	0.000115	CbGpPWpGaD
Naproxen—PTGS2—Disease—INS—Parkinson's disease	0.000114	0.000114	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ABCB1—Parkinson's disease	0.000114	0.000114	CbGpPWpGaD
Naproxen—ALB—Metabolism—ABCB1—Parkinson's disease	0.000113	0.000113	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—APOE—Parkinson's disease	0.000112	0.000112	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—CYCS—Parkinson's disease	0.000111	0.000111	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	0.000111	0.000111	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GSTM1—Parkinson's disease	0.00011	0.00011	CbGpPWpGaD
Naproxen—ALB—Metabolism—GSTM1—Parkinson's disease	0.00011	0.00011	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CTGF—Parkinson's disease	0.000109	0.000109	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—GPX1—Parkinson's disease	0.000106	0.000106	CbGpPWpGaD
Naproxen—ALB—Metabolism—GPX1—Parkinson's disease	0.000105	0.000105	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	0.000101	0.000101	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6—Parkinson's disease	0.000101	0.000101	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NQO1—Parkinson's disease	0.0001	0.0001	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—TH—Parkinson's disease	9.86e-05	9.86e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—COMT—Parkinson's disease	9.81e-05	9.81e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTP1—Parkinson's disease	9.77e-05	9.77e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—MTHFR—Parkinson's disease	9.75e-05	9.75e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MAOA—Parkinson's disease	9.74e-05	9.74e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—MTHFR—Parkinson's disease	9.69e-05	9.69e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—HMOX1—Parkinson's disease	9.63e-05	9.63e-05	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—INS—Parkinson's disease	9.53e-05	9.53e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—CYCS—Parkinson's disease	9.47e-05	9.47e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ABCB1—Parkinson's disease	9.25e-05	9.25e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—APOE—Parkinson's disease	9.07e-05	9.07e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—APOE—Parkinson's disease	9.02e-05	9.02e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GSTM1—Parkinson's disease	8.98e-05	8.98e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—GPX1—Parkinson's disease	8.6e-05	8.6e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—COMT—Parkinson's disease	8.39e-05	8.39e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTP1—Parkinson's disease	8.35e-05	8.35e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MAOA—Parkinson's disease	8.33e-05	8.33e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—HMOX1—Parkinson's disease	8.23e-05	8.23e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—MTHFR—Parkinson's disease	7.93e-05	7.93e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ABCB1—Parkinson's disease	7.9e-05	7.9e-05	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—INS—Parkinson's disease	7.75e-05	7.75e-05	CbGpPWpGaD
Naproxen—ALB—Metabolism—INS—Parkinson's disease	7.71e-05	7.71e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GSTM1—Parkinson's disease	7.67e-05	7.67e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—APOE—Parkinson's disease	7.38e-05	7.38e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—GPX1—Parkinson's disease	7.35e-05	7.35e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—MTHFR—Parkinson's disease	6.78e-05	6.78e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—APOE—Parkinson's disease	6.31e-05	6.31e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—INS—Parkinson's disease	6.31e-05	6.31e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—INS—Parkinson's disease	5.39e-05	5.39e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6—Parkinson's disease	4.97e-05	4.97e-05	CbGpPWpGaD
